Detalhe da pesquisa
1.
Transcriptomic signatures of tumors undergoing T cell attack.
Cancer Immunol Immunother
; 71(3): 553-563, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34272988
2.
The effects of targeted immune-regulatory strategies on tumor-specific T-cell responses in vitro.
Cancer Immunol Immunother
; 70(6): 1771-1776, 2021 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-33165629
3.
Common phenotypic dynamics of tumor-infiltrating lymphocytes across different histologies upon checkpoint inhibition: impact on clinical outcome.
Cytotherapy
; 22(4): 204-213, 2020 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32201034
4.
Differential effects of corticosteroids and anti-TNF on tumor-specific immune responses: implications for the management of irAEs.
Int J Cancer
; 145(5): 1408-1413, 2019 09 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30575963
5.
Cancer immunotherapy in patients with brain metastases.
Cancer Immunol Immunother
; 67(5): 703-711, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29520474
6.
Dose escalation study of a personalized peptide-based neoantigen vaccine (EVX-01) in patients with metastatic melanoma.
J Immunother Cancer
; 12(5)2024 May 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-38782542
7.
Uncoupling CD4+ TIL-Mediated Tumor Killing from JAK-Signaling in Melanoma.
Clin Cancer Res
; 29(19): 3937-3947, 2023 10 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-37126006
8.
Immunologic Characterization and T cell Receptor Repertoires of Expanded Tumor-infiltrating Lymphocytes in Patients with Renal Cell Carcinoma.
Cancer Res Commun
; 3(7): 1260-1276, 2023 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-37484198
9.
Phase 2 study of ipilimumab, nivolumab, and tocilizumab combined with stereotactic body radiotherapy in patients with refractory pancreatic cancer (TRIPLE-R).
Eur J Cancer
; 180: 125-133, 2023 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-36592507
10.
TCR-engaging scaffolds selectively expand antigen-specific T-cells with a favorable phenotype for adoptive cell therapy.
J Immunother Cancer
; 11(8)2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37586765
11.
Coexisting Alterations of MHC Class I Antigen Presentation and IFNγ Signaling Mediate Acquired Resistance of Melanoma to Post-PD-1 Immunotherapy.
Cancer Immunol Res
; 10(10): 1254-1262, 2022 10 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-35969233
12.
Neoantigen-reactive CD8+ T cells affect clinical outcome of adoptive cell therapy with tumor-infiltrating lymphocytes in melanoma.
J Clin Invest
; 132(2)2022 01 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-34813506
13.
Personalized therapy with peptide-based neoantigen vaccine (EVX-01) including a novel adjuvant, CAF®09b, in patients with metastatic melanoma.
Oncoimmunology
; 11(1): 2023255, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-35036074
14.
Rapid Identification of the Tumor-Specific Reactive TIL Repertoire via Combined Detection of CD137, TNF, and IFNγ, Following Recognition of Autologous Tumor-Antigens.
Front Immunol
; 12: 705422, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34707600
15.
Tumor-Infiltrating T Cells From Clear Cell Renal Cell Carcinoma Patients Recognize Neoepitopes Derived From Point and Frameshift Mutations.
Front Immunol
; 11: 373, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32226429
16.
Qualitative Analysis of Tumor-Infiltrating Lymphocytes across Human Tumor Types Reveals a Higher Proportion of Bystander CD8+ T Cells in Non-Melanoma Cancers Compared to Melanoma.
Cancers (Basel)
; 12(11)2020 Nov 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-33198174
17.
Acquired resistance to cancer immunotherapy.
Semin Immunopathol
; 41(1): 31-40, 2019 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29968044
18.
MERTK Acts as a Costimulatory Receptor on Human CD8+ T Cells.
Cancer Immunol Res
; 7(9): 1472-1484, 2019 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-31266785